These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27896891)

  • 21. Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3/MCL-1 survival signaling and retards B16-F10 melanoma growth in vivo.
    Or CR; Su HL; Lee WC; Yang SY; Ho C; Chang CC
    Oncol Rep; 2016 Dec; 36(6):3465-3471. PubMed ID: 27779705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4.
    Mo X; Zhang H; Preston S; Martin K; Zhou B; Vadalia N; Gamero AM; Soboloff J; Tempera I; Zaidi MR
    Cancer Res; 2018 Jan; 78(2):436-450. PubMed ID: 29150430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production.
    Kim A; Im M; Yim NH; Ma JY
    Sci Rep; 2014 Nov; 4():6994. PubMed ID: 25385232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling.
    Cao HH; Tse AK; Kwan HY; Yu H; Cheng CY; Su T; Fong WF; Yu ZL
    Biochem Pharmacol; 2014 Feb; 87(3):424-34. PubMed ID: 24275163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
    Wu ZS; Cheng XW; Wang XN; Song NJ
    Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy.
    Wang W; Edington HD; Rao UN; Jukic DM; Wang H; Shipe-Spotloe JM; Kirkwood JM
    J Invest Dermatol; 2008 Aug; 128(8):1997-2002. PubMed ID: 18305569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.
    Delyon J; Chevret S; Jouary T; Dalac S; Dalle S; Guillot B; Arnault JP; Avril MF; Bedane C; Bens G; Pham-Ledard A; Mansard S; Grange F; Machet L; Meyer N; Legoupil D; Saiag P; Idir Z; Renault V; Deleuze JF; Hindie E; Battistella M; Dumaz N; Mourah S; Lebbe C;
    J Invest Dermatol; 2018 Jan; 138(1):58-67. PubMed ID: 28843487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
    Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
    Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.
    Zhang L; Tao L; Shi T; Zhang F; Sheng X; Cao Y; Zheng S; Wang A; Qian W; Jiang L; Lu Y
    IUBMB Life; 2015 Oct; 67(10):778-88. PubMed ID: 26452780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geranylnaringenin (CG902) inhibits constitutive and inducible STAT3 activation through the activation of SHP-2 tyrosine phosphatase.
    Jin Y; Yoon YJ; Jeon YJ; Choi J; Lee YJ; Lee J; Choi S; Nash O; Han DC; Kwon BM
    Biochem Pharmacol; 2017 Oct; 142():46-57. PubMed ID: 28666623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival.
    Pietrobono S; Morandi A; Gagliardi S; Gerlini G; Borgognoni L; Chiarugi P; Arbiser JL; Stecca B
    J Invest Dermatol; 2016 Oct; 136(10):2059-2069. PubMed ID: 27373978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EGR1-STAT3 Transcription Factor Axis Regulates α-Melanocyte-Stimulating Hormone-Induced Tyrosinase Gene Transcription in Melanocytes.
    Shin SY; Choi JH; Jung E; Gil HN; Lim Y; Lee YH
    J Invest Dermatol; 2019 Jul; 139(7):1616-1619. PubMed ID: 30648541
    [No Abstract]   [Full Text] [Related]  

  • 33. Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cells.
    Sakaguchi M; Oka M; Iwasaki T; Fukami Y; Nishigori C
    J Invest Dermatol; 2012 Jul; 132(7):1877-85. PubMed ID: 22418867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Tan SM; Li F; Rajendran P; Kumar AP; Hui KM; Sethi G
    J Pharmacol Exp Ther; 2010 Jul; 334(1):285-93. PubMed ID: 20378717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
    Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
    Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
    Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
    Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
    Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
    Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
    Swoboda A; Soukup R; Eckel O; Kinslechner K; Wingelhofer B; Schörghofer D; Sternberg C; Pham HTT; Vallianou M; Horvath J; Stoiber D; Kenner L; Larue L; Poli V; Beermann F; Yokota T; Kubicek S; Krausgruber T; Rendeiro AF; Bock C; Zenz R; Kovacic B; Aberger F; Hengstschläger M; Petzelbauer P; Mikula M; Moriggl R
    Oncogene; 2021 Feb; 40(6):1091-1105. PubMed ID: 33323974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells.
    Xu Z; Sun Y; Guo Y; Qin G; Mu S; Fan R; Wang B; Gao W; Wu H; Wang G; Zhang Z
    Oncol Rep; 2016 Jun; 35(6):3630-8. PubMed ID: 27109360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.
    Kamran MZ; Gude RP
    Biomed Pharmacother; 2013 Jun; 67(5):399-405. PubMed ID: 23639230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.